Differential cellular and humoral immune responses to HCV core and HBV envelope proteins after genetic immunizations using chimeric constructs

Vaccine

Volumn 16, Issue 8, 1998, Pages 857-867

  Geissler, Michael ^a,e   Tokushige, Katsutoshi ^a,b   Wakita, Takaji ^a,c   Zurawski Jr , Vincent R ^d   Wands, Jack R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d Apollon   (United States)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Antibody; Cytokines; Helper T cells; Secretion

Indexed keywords

BUPIVACAINE; CD4 ANTIGEN; CD8 ANTIGEN; CHIMERIC PROTEIN; ENVELOPE PROTEIN; STRUCTURAL PROTEIN; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE CONSTRUCT; GENE EXPRESSION; HELPER CELL; HEPATITIS B; HEPATITIS C VIRUS; HUMORAL IMMUNITY; IMMUNOGENICITY; IN VITRO STUDY; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0032077308     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00236-3     Document Type: Article

References (43)

1. 1 Tang, D., DeVit, M. and Johnston, S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 1992, 356, 152-154.
2. 2 Wolff, J.A., Malone, R.W., Williams, P. et al. Direct gene transfer into mouse muscle in vivo. Science 1990, 247, 1465-1468.
3. 3 Martins, L.P., Lau, L.L., Asano, M.S. and Ahmed, R. DNA vaccination against persistent viral infection. J. Virol. 1995, 69, 2574-2582.
4. 4 Donelly, J.J., Friedman, A. and Martinez, D. et al. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nature Medicine 1995, 1, 583-587.
5. 5 Manickan, E., Rouse, R.J., Yu, Z., Wire, W.S. and Rouse, B.T. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J. Immunol. 1995, 155, 259-265.
6. 6 Wang, B., Merva, M., Dang, K. et al. DNA inoculation induces protective in vivo immune responses against cellular challenge with HIV-1 antigen-expressing cells. Aids Res. Hum. Retroviruses 1994, 10, S35-S41.
7. 7 Xiang, Z.Q., Spitalnik, S., Tran, M., Wunner, W.H., Cheng, J. and Ertl, H.C. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 1994, 199, 132-140.
8. 8 Xiang, Z.Q., Spitalnik, S.L., Cheng, J., Erikson, J., Wojczyk, B. and Ertl, H.C. Immune responses to nucleic acid vaccines to rabies virus. Virology 1995, 209, 569-579.
9. 9 Yankauckas, M.A., Morrow, J.E., Parker, S.E., Abai, A., Rhodes, G.H., Dwarki, V.J. and Gromkowski, S.H. Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene. DNA and Cell Biol. 1993, 9, 771-776.
10. 10 Yasutomi, Y., Robinson, H.L. and Lu, S. et al. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J. Virol. 1996, 70, 678-681.
11. 11 Yokoyama, M., Zhang, J. and Whitton, J.L. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 1995, 69, 2684-2688.
12. 12 Geissler, M., Tokushige, K. and Wands, J. Cellular and humoral immune response to hepatitis B virus structural proteins in mice following DNA-based immunization. Gastroenterology 1997, 112, 1307-1320.
13. b mice. J. Immunol. 1996, 156, 3687-3695.
14. 14 Schirmbeck, R., Bohm, W., Ando, K., Chisari, F.V. and Reimann, J. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J. Virol. 1995, 69, 5929-5934.
15. 15 Geissler, M., Gesien, A., Tokushige, K. and Wands, J.R. Enhancement of cellular and humoral immune responses to hepatitis C virus (HCV) core protein using DNA based vaccines augmented with cytokine expressing plasmids. J. Immunol. 1997, 158, 1231-1237.
16. 16 Lagging, L.M., Meyer, K., Hoft, D., Houghton, M., Belshe, R.B. and Ray, R. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J. Virol. 1995, 69, 5859-5863.
17. 17 Tokushige, K.T.W., Pachuk, C., Moradpour, D., Weiner, D., Zurawski, V.R. Jr.Jr and Wands, J.R. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. Hepatology 1996, 24, 14-20.
18. 18 Missale, G., Bertoni, R. and Lamonaca, V. et al. Different clinical bheaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J. Clin. Invest. 1996, 98, 706-714.
19. 19 Wong, D., Dudley, D., Afdhal, N. et al. Liver derived cytotoxic T lymphocytes in non resolving hepatitis C infection. In: IX Triennial International Symposium on Viral Hepatitis and Liver Disease 1996, Abstract D44, p. 294.
20. 20 Geissler, M., Gesien, A. and Wangs, J.R. The inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein is reversed by genetic immunizations augmented with cytokine expressing plasmids. J. Immunol. 1997, 159, 5107-5113.
21. 21 Santolini, E., Migliaccio, G. and LaMonica, N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J. Virol. 1994, 68, 3631-3641.
22. 22 Shirai, M., Okada, H. and Nishioka, M. et al. An epitope in hepatitis C virus core region recognized by cototoxic T cells in mice and humans. J. Virol. 1994, 68, 3334-3342.
23. 23 Kakimi, K., Kuribayashi, K., Iwashiro, M. et al. Hepatitis C virus core region: helper T cell epitopes recognized by BALB/c and C57BL/6 mice. J. Gen. Virol. 1995, 76, 1205-1214.
24. 24 Tokushige, K., Moradpour, D.T.W., Geissler, M., Hayashi, N. and Wands, J.R. Comparison between cytomegalovirus promoter and elongation factor-1a promoter-driven constructs in the establishment of cell lines expressing hepatitis C virus core protein. J. Virol. Methods 1997, 64, 73-80.
25. 25 Blum, H.E., Galun, E., Liang, T.J., Weizsacker von, F. and Wands, J.R. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J. Virol. 1991, 65, 1836-1842.
26. 26 Sells, M.A., Chen, M.L. and Acs, G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl Acad. Sci. USA 1987, 84, 1005-1009.
27. 27 Heermann, K.H., Goldmann, U., Schwartz, W., Seyffarth, T., Baumgarten, H. and Gerlich, W.H. Large surface proteins of hepatitis B virus containing the pre-s sequence. J. Virol. 1984, 52, 396-402.
28. 28 Heermann, K.H., Kruse, F., Seifer, M. and Gerlich, W.H. Immunogeneicity of the S and Pre-S gene domains in hepatitis B virions and HBsAg filaments. Intervirology 1987, 28, 14-25.
29. 29 Ben Porath, E., Wands, J.R. and Marciniak, R.A. et al. Structural analysis of hepatitis B surface antigen by monoclonal antibodies. J. Clin. Invest. 1985, 76, 1338-1347.
30. 30 Moradpour, D., Wakita, T., Tokushige, K., Carlson, R.I., Krawczynski, K. and Wands, J.R. Characterization of three novel monoclonal antibodies against hepatitis C virus core protein. J. Med. Virol. 1996, 48, 234-241.
31. 31 Geissler, M., Gesien, A. and Wands, J.R. Chronic ethanol effects on cellular immune responses to hepatitis B virus envelope protein: an immunologic mechanism for induction of persistent viral infection in alcoholics. Hepatology 1997, 26, 764-770.
32. 32 Geissler, M., Wands, G., Gesien, A., Bellet, D., delaMonte, S. and Wands, J. Genetic immunization with the free human chorionic gonadotropin b subunit elicits cytotoxic T lymphocyte responses and protects against tumor formation in mice. Lab. Invest. 1997, 76, 859-871.
33. 33 Marquardt, O., Heermann, K.H., Seifer, M. and Gerlich, W.H. Cell type specific expression of pre S 1 antigen and secretion of hepatitis B virus surface antigen (brief report). Arch. Virol. 1987, 96, 249-256.
34. 34 Persing, D.H., Varmus, H.E. and Ganem, D. Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. Science 1986, 234, 1388-1391.
35. 35 Major, M.E., Vitvitski, L. and Mink, M.A. et al. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J. Virol. 1995, 69, 5798-5805.
36. 36 Michel, M.L., Mancini, M. and Sobczak, E. et al. Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV-hepalitis B surface antigen particles. Proc. Natl Acad. Sci. USA 1988, 85, 7957-7961.
37. 37 Delpeyroux, F., Chenciner, N. and Lim, A. et al. A poliovirus neutralization epitope expressed on hybrid hepatitis B surface antigen particles. Science 1986, 233, 472-475.
38. 38 Rehermann, B., Chang, K.M. and McHutchinson, J. et al. Differential cytotoxic T lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J. Virol. 1996, 70, 7092-7102.
39. 39 Rehermann, B., Chang, K.M., McHutchinson, J., Kokka, R., Houghton, M. and Chisari, F.V. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J. Clin. Invest. 1996, 98, 1432-1440.
40. 40 Ehl, S., Hombach, J., Aichele, P., Hengartner, H. and Zinkernagel, R.M. Bystander activation of cytotoxic T cells: studies on the mechanicam and evaluation of in vivo significance in a transgenic mouse model. J. Exp. Med. 1997, 185, 1241-1251.
41. 41 Selin, L.K., Nahill, S.R. and Welsh, R.M. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J. Exp. Med. 1994, 179, 1933-1943.
42. 42 Zaronski, C.R. and Welsh, R. Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response. J. Exp. Med. 1997, 185, 1629-1639.
43. 43 Bakker, A.B., van der Burg, S.H. and Huijbens, R.J. Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope. Int. J. Cancer 1997, 70, 302-309.